Avionco Overview

  • Founded
  • 2009
  • Status
  • Out of Business
  • Latest Deal Type
  • Out of Business

Avionco General Information


Developer of novel cancer drugs designed to treat disease models relevant to cancer in humans. The company's drugs aim to make a contribution to the development of the Russian pharmaceutical industry through running experiments using specialized equipment for identifying the anti-tumor activity of drug candidates, enabling cancer patients to improve the quality of life with new generation drugs and medication.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Primary Office
  • Rabochaya Street, 2a, Building 1
  • Khimki, Moscow 141400
  • Russia
+7 8 (000) 000-00-00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Avionco Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Out of Business 03-Dec-2020 Completed Out of Business
2. Grant 09-Jun-2010 00000 Completed Generating Revenue
1. Early Stage VC Completed Startup
To view Avionco’s complete valuation and funding history, request access »